Zions Bancorporation, National Association’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Buy
10,854
+6,002
+124% +$791K 0.08% 132
2026
Q1
$676K Sell
4,852
-29,986
-86% -$4.2M 0.04% 224
2025
Q4
$4.28M Sell
34,838
-5,334
-13% -$648K 0.2% 81
2025
Q3
$4.46M Sell
40,172
-18,883
-32% -$2.15M 0.22% 78
2025
Q2
$6.55M Sell
59,055
-34,687
-37% -$3.69M 0.35% 60
2025
Q1
$10.5M Buy
+93,742
New +$9.67M 0.66% 25

Other funds holding GILD

Zions Bancorporation, National Association's GILD Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Gilead Sciences (GILD) stake by 124% in Q2 2026, buying an estimated $791K and bringing the position to 10,854 shares worth $1.37M. The position accounts for 0.08% of the portfolio, ranked #132.

Zions Bancorporation, National Association first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $10.5M in Q1 2025. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Zions Bancorporation, National Association held 10,854 shares of Gilead Sciences worth $1.37M as of Q2 2026.
  • Zions Bancorporation, National Association bought 6,002 Gilead Sciences shares in Q2 2026, an estimated $791K.
  • Gilead Sciences made up 0.08% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #132 holding.
  • Zions Bancorporation, National Association first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's Gilead Sciences position peaked at $10.5M in Q1 2025.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.